BridgeMD
New treatment option for Metatarsalgia
Official title Randomized Controlled Trial of Custom Foot Orthoses for Chronic Forefoot Pain
ClinicalTrials.gov ID: NCT06962475
What this study is testing
- What it's testing
- Background Chronic metatarsalgia (CM) causes significant pain and disability, affecting quality of life. Foot orthoses (FOs) including medially wedged designs with a metatarsal pad decrease excessive plantar pressure under the metatarsal heads, which is a suggested risk factor for developing CM.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- are aged 18 years or over,
- have bilateral or unilateral metatarsalgia under one or more of the lesser metatarsal heads for at least 3 months (pain score of ≥ 4 out of 10 on a...
- are able to walk without assistive devices (e.g., cane, walker),
- are willing to wear shoes that will accommodate their FOs on a daily basis and
- are willing to minimize the use of other interventions (e.g., pain medications, physical therapy) during the trial period
You likely can't join if
- have arthritis,
- have neurological diseases (e.g., intermetatarsal neuroma) or other mechanical pain, plantar corns (e.g., intractable plantar keratoma),
- have a history of orthopedic foot surgery,
- have prior use of customized FOs,
- have cognitive impairments,
- are pregnant.
The study team makes the final eligibility decision.
Where it's taking place
- Trois-Rivières, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Trois-Rivières, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.